ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.53B
Enterprise Value 31.26B
Trailing P/E 19.98
Forward P/E 137.60
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.11
Price/Book (mrq)4.24
Enterprise Value/Revenue 35.83
Enterprise Value/EBITDA 611.36

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 37.63%
Operating Margin (ttm)50.23%

Management Effectiveness

Return on Assets (ttm)20.65%
Return on Equity (ttm)26.01%

Income Statement

Revenue (ttm)215.35M
Revenue Per Share (ttm)11.23
Quarterly Revenue Growth (yoy)662.40%
Gross Profit (ttm)102.81M
EBITDA 110.59M
Net Income Avi to Common (ttm)81.04M
Diluted EPS (ttm)3.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)273.23M
Total Cash Per Share (mrq)14.1
Total Debt (mrq)1.84M
Total Debt/Equity (mrq)0.51
Current Ratio (mrq)24.23
Book Value Per Share (mrq)18.64

Cash Flow Statement

Operating Cash Flow (ttm)58.19M
Levered Free Cash Flow (ttm)32.77M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.65
52-Week Change 363.43%
S&P500 52-Week Change 37.95%
52 Week High 3127.77
52 Week Low 344.52
50-Day Moving Average 384.99
200-Day Moving Average 397.96

Share Statistics

Avg Vol (3 month) 3274.46k
Avg Vol (10 day) 3195.47k
Shares Outstanding 519.38M
Float 13.71M
% Held by Insiders 124.31%
% Held by Institutions 178.31%
Shares Short (Sep 28, 2018) 42.21M
Short Ratio (Sep 28, 2018) 48.67
Short % of Float (Sep 28, 2018) 413.96%
Short % of Shares Outstanding (Sep 28, 2018) 411.40%
Shares Short (prior month Aug 31, 2018) 41.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A